Literature DB >> 23658016

High density lipoprotein protects against polymicrobe-induced sepsis in mice.

Ling Guo1, Junting Ai, Zhong Zheng, Deborah A Howatt, Alan Daugherty, Bin Huang, Xiang-An Li.   

Abstract

HDL has been considered to be a protective factor in sepsis; however, most contributing studies were conducted using the endotoxic animal model, and evidence from clinically relevant septic animal models remains limited and controversial. Furthermore, little is known about the roles of HDL in sepsis other than LPS neutralization. In this study, we employed cecal ligation and puncture (CLP), a clinically relevant septic animal model, and utilized apoA-I knock-out (KO) and transgenic mice to elucidate the roles of HDL in sepsis. ApoA-I-KO mice were more susceptible to CLP-induced septic death as shown by the 47.1% survival of apoA-I-KO mice versus the 76.7% survival of C57BL/6J (B6) mice (p = 0.038). ApoA-I-KO mice had exacerbated inflammatory cytokine production during sepsis compared with B6 mice. Further study indicated that serum from apoA-I-KO mice displayed less capacity for LPS neutralization compared with serum from B6 mice. In addition, apoA-I-KO mice had less LPS clearance, reduced corticosterone generation, and impaired leukocyte recruitment in sepsis. In contrast to apoA-I-KO mice, apoA-I transgenic mice were moderately resistant to CLP-induced septic death compared with B6 mice. In conclusion, our findings reveal multiple protective roles of HDL in CLP-induced sepsis. In addition to its well established role in neutralization of LPS, HDL exerts its protection against sepsis through promoting LPS clearance and modulating corticosterone production and leukocyte recruitment. Our study supports efforts to raise HDL levels as a therapeutic approach for sepsis.

Entities:  

Keywords:  Apolipoprotein A-I; Cecal Ligation and Puncture; Dyslipidemia; High Density Lipoprotein (HDL); Immunology; Lipopolysaccharide (LPS); SCARB1; Scavenger Receptor BI; Sepsis

Mesh:

Substances:

Year:  2013        PMID: 23658016      PMCID: PMC3689940          DOI: 10.1074/jbc.M112.442699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 2.  Antiinflammatory properties of HDL.

Authors:  Philip J Barter; Stephen Nicholls; Kerry-Anne Rye; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman
Journal:  Circ Res       Date:  2004-10-15       Impact factor: 17.367

Review 3.  Novel biological functions of high-density lipoprotein cholesterol.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2012-09-28       Impact factor: 17.367

4.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

5.  New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides.

Authors:  R J Ulevitch; A R Johnston; D B Weinstein
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

Review 6.  Management of severe sepsis and septic shock.

Authors:  Curtis N Sessler; John C Perry; Kimberly L Varney
Journal:  Curr Opin Crit Care       Date:  2004-10       Impact factor: 3.687

7.  Lipoprotein metabolism in patients with severe sepsis.

Authors:  Henk J van Leeuwen; Eric C J M Heezius; Geesje M Dallinga; Jos A G van Strijp; Jan Verhoef; Kok P M van Kessel
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

8.  Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network.

Authors:  Andrés Vazquez-Torres; Bruce A Vallance; Molly A Bergman; B Brett Finlay; Brad T Cookson; Jessica Jones-Carson; Ferric C Fang
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

Review 9.  The enigma of sepsis.

Authors:  Niels C Riedemann; Ren-Feng Guo; Peter A Ward
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1.

Authors:  Tatyana G Vishnyakova; Alexander V Bocharov; Irina N Baranova; Zhigang Chen; Alan T Remaley; Gyorgy Csako; Thomas L Eggerman; Amy P Patterson
Journal:  J Biol Chem       Date:  2003-03-21       Impact factor: 5.157

View more
  39 in total

1.  Associations of lipoproteins with cardiovascular and infection-related outcomes in patients receiving hemodialysis.

Authors:  George A Kaysen; Barbara Grimes; Lorien S Dalrymple; Glenn M Chertow; Julie H Ishida; Cynthia Delgado; Mark Segal; Janet Chiang; Tjien Dwyer; Kirsten L Johansen
Journal:  J Clin Lipidol       Date:  2017-12-27       Impact factor: 4.766

Review 2.  Lipid testing in infectious diseases: possible role in diagnosis and prognosis.

Authors:  Sebastian Filippas-Ntekouan; Evangelos Liberopoulos; Moses Elisaf
Journal:  Infection       Date:  2017-05-08       Impact factor: 3.553

3.  Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein.

Authors:  Zhili Yao; Jessica M Mates; Alana M Cheplowitz; Lindsay P Hammer; Andrei Maiseyeu; Gary S Phillips; Mark D Wewers; Murugesan V S Rajaram; John M Robinson; Clark L Anderson; Latha P Ganesan
Journal:  J Immunol       Date:  2016-08-17       Impact factor: 5.422

4.  Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

5.  Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis: A Preliminary Investigation.

Authors:  Faheem W Guirgis; Sunita Dodani; Lyle Moldawer; Christiaan Leeuwenburgh; Jennifer Bowman; Colleen Kalynych; Alan E Jones; Srinivasa T Reddy; Frederick A Moore
Journal:  Shock       Date:  2017-11       Impact factor: 3.454

6.  HDL and Sepsis.

Authors:  Huanhuan Cao; Wei Huang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis.

Authors:  Maryam Zamanian-Daryoush; Valentin Gogonea; Anthony J DiDonato; Jennifer A Buffa; Ibrahim Choucair; Bruce S Levison; Randall A Hughes; Andrew D Ellington; Ying Huang; Xinmin S Li; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2020-02-25       Impact factor: 5.157

8.  Serum amyloid A links endotoxaemia to weight gain and insulin resistance in mice.

Authors:  Edson M de Oliveira; Thais P Ascar; Jacqueline C Silva; Silvana Sandri; Silene Migliorini; Ricardo A Fock; Ana Campa
Journal:  Diabetologia       Date:  2016-04-28       Impact factor: 10.122

9.  Human SR-BI and SR-BII Potentiate Lipopolysaccharide-Induced Inflammation and Acute Liver and Kidney Injury in Mice.

Authors:  Irina N Baranova; Ana C P Souza; Alexander V Bocharov; Tatyana G Vishnyakova; Xuzhen Hu; Boris L Vaisman; Marcelo J Amar; Zhigang Chen; Yana Kost; Alan T Remaley; Amy P Patterson; Peter S T Yuen; Robert A Star; Thomas L Eggerman
Journal:  J Immunol       Date:  2016-03-02       Impact factor: 5.422

10.  High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion.

Authors:  Dominic W Chung; Junmei Chen; Minhua Ling; Xiaoyun Fu; Teri Blevins; Scott Parsons; Jennie Le; Jeff Harris; Thomas R Martin; Barbara A Konkle; Ying Zheng; José A López
Journal:  Blood       Date:  2015-11-09       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.